Skip to content

Acupuncture, Counselling, and Usual GP care for Depression (ACUDep)

Acupuncture, Counselling, and Usual GP care for Depression (ACUDep): a randomised controlled trial to evaluate effectiveness and cost-effectiveness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN63787732
Enrollment
640
Registered
2009-12-15
Start date
2009-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Mental and Behavioural Disorders Depressive episode

Interventions

Patients allocated to the acupuncture and counselling groups will receive the offer of 12 sessions on a weekly basis. The participating acupuncturists will be members of the British Acupuncture Counc

Sponsors

University of York (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients over 18 who have consulted their GP for depression 2. Participants must also be still be depressed at the time of recruitment, with a score of 20 or above on the Beck Depression Inventory-II

Exclusion criteria

Exclusion criteria: 1. Patients who are receiving acupuncture or counselling sessions 2. Terminal illness 3. Haemophilia 4. Hepatitis 5. Human immunodeficiency virus (HIV) 6. Pregnancy 7. Confounding psychiatric condition: 7.1. Bipolar disorder 7.2. Postpartum depression 7.3. Adjustment disorder 7.4. Psychosis 7.5. Personality disorder 8. Suffered a close personal bereavement 9. Given birth during the previous 12 months 10. Because of the specific demands of this study in terms of the need to fully comprehend detailed information, to complete questionnaires, to understand and converse readily with English speaking acupuncturists and counsellors, and to permit physical contact, we intend to exclude patients who have a significant learning disability, who are unable to converse in English, or who have dementia

Design outcomes

Primary

MeasureTime frame
The Patient Health Questionnaire-9 (PHQ-9) at three months, with an evaluation of whether there is an overall benefit over the twelve months. We will use the correlation between the PHQ-9 and Beck Depression Inventory-II (BDI-II) at baseline and 12 months to determine equivalent BDI-II scores at subsequent timepoints.

Secondary

MeasureTime frame
1. SF-36 Bodily Pain Subscale 2. EQ-5D 3. CARE (Consultational and Relational Empathy measure) 4. We will also collect data on NHS resource use and patients' private costs

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026